1986
DOI: 10.1002/chin.198619236
|View full text |Cite
|
Sign up to set email alerts
|

ChemInform Abstract: 2‐Acetylpyridine Thiosemicarbazones. Part 12. Derivatives of 3‐Acetylisoquinoline as Potential Antimalarial Agents.

Abstract: Das 3‐Acetylisochinolin (I) kondensiert mit dem Dithiocarbazidsäuremethylester (II) zum Hydrazon (III), das sich mit NaBH4 zum Hydrazinodithiocarbonsäureester (IV) hydrieren läßt. Die sekundären Amine (VI) liefern mit (III) die Thiosemicarbazone (V); mit (IV) entstehen die Thiosemicarbazide (VII).

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
4
0

Year Published

1998
1998
2017
2017

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(5 citation statements)
references
References 0 publications
1
4
0
Order By: Relevance
“…Not only does this identify benzohydroxamate as a potential antimalarial, but in addition and perhaps more importantly, it provides evidence of a difference between P. falciparum and human RNRs. This evidence supports that of Klayman et al (9,10), who cured Plasmodium berghei malaria in mice with RNR inhibitors, suggesting a possible difference between the P. berghei and mouse forms of reductase. Unlike the P. berghei data, the P. falciparum result presented here could not be explained by a difference in drug permeability, since benzohydroxamate was more effective in inhibiting the P. falciparum reductase enclosed within the parasite than the human enzyme, which was free in solution.…”
supporting
confidence: 90%
“…Not only does this identify benzohydroxamate as a potential antimalarial, but in addition and perhaps more importantly, it provides evidence of a difference between P. falciparum and human RNRs. This evidence supports that of Klayman et al (9,10), who cured Plasmodium berghei malaria in mice with RNR inhibitors, suggesting a possible difference between the P. berghei and mouse forms of reductase. Unlike the P. berghei data, the P. falciparum result presented here could not be explained by a difference in drug permeability, since benzohydroxamate was more effective in inhibiting the P. falciparum reductase enclosed within the parasite than the human enzyme, which was free in solution.…”
supporting
confidence: 90%
“…The following ketones utilized as starting materials were obtained according to the literature cited: methyl 3-pyridazinyl ketone ( 12a ), methyl 3-(6-methylpyridazinyl) ketone ( 12b ), methyl 2-pyrimidinyl ketone ( 12c ), methyl 4-pyrimidinyl ketone ( 12d ), methyl 4-(6-methylpyrimidinyl) ketone ( 12e ), methyl 2-(5-methylpyrazinyl) ketone ( 12h ), 2-acetylquinoline ( 12i ), 1-acetylisoquinoline ( 12j ), and 3-acetylisoquinoline ( 12k ) . Methyl 2-pyrazinyl ketone ( 12f ) and methyl 2-(3-methylpyrazinyl) ketone ( 12g ) were purchased from Maybridge Co. 2-Benzoylpyridine ( 10g ) and di-(pyridin-2-yl)-methanone ( 10h ) were purchased from Sigma-Aldrich Co.…”
Section: Methodsmentioning
confidence: 99%
“…Hydroxyurea is a useful drug in therapy of leukaemia and other malignant tumour diseases and its derivative zileuton is an orally active inhibitor of 5-lipoxygenase which is used for the maintenance treatment of asthma 12 . Hydroxyurea is an inhibitor of ribonucleotide reductase, the enzyme described as a target for the chemotherapy of both malignant diseases and malaria 13,14 . Mahajan et aldescribed 7-chloroquinolyl thioureas as potential antimalarial and anticancer agents 15 .…”
Section: Introductionmentioning
confidence: 99%